Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society

被引:0
|
作者
Stig Evensen
Torbjørn Wisløff
June Ullevoldsæter Lystad
Helen Bull
Egil W. Martinsen
Torill Ueland
Erik Falkum
机构
[1] Oslo University Hospital,Department of Research, Division of Mental Health and Addiction
[2] Norwegian Institute of Public Health,Department of Infectious Disease Epidemiology and Modelling
[3] University of Oslo,Department of Clinical Medicine
[4] University of Oslo,Department of Psychology
[5] University of Oslo,Department of Health Management and Health Economics
来源
关键词
Schizophrenia; Vocational rehabilitation; Quality adjusted life years (QALY); Cognitive behaviour therapy; Cognitive remediation; Incremental cost-effectiveness ratio;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 38 条
  • [31] Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds
    Daroudi, Rajabali
    Sari, Ali Akbari
    Nahvijou, Azin
    Faramarzi, Ahmad
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [32] Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country
    Fekadu, Ginenus
    Jiang, Xinchan
    Yao, Jiaqi
    You, Joyce H. S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 271 - 278
  • [33] Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting
    Bruijning-Verhagen, P.
    van Dongen, J. A. P.
    Verberk, J. D. M.
    Pijnacker, R.
    van Gaalen, R. D.
    Klinkenberg, D.
    de Melker, H. E.
    Mangen, M-J J.
    BMC MEDICINE, 2018, 16
  • [34] Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting
    P. Bruijning-Verhagen
    J. A. P. van Dongen
    J. D. M. Verberk
    R. Pijnacker
    R. D. van Gaalen
    D. Klinkenberg
    H. E. de Melker
    M.-J. J. Mangen
    BMC Medicine, 16
  • [35] Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission
    Uhlenhopp, Dustin J.
    Aguilar, Oscar
    Dai, Dong
    Ghosh, Arka
    Shaw, Michael
    Mitra, Chandan
    INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2020, 9 : 195 - 203
  • [36] Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program
    Sathish, Thirunavukkarasu
    Oldenburg, Brian
    Thankappan, Kavumpurathu R.
    Absetz, Pilvikki
    Shaw, Jonathan E.
    Tapp, Robyn J.
    Zimmet, Paul Z.
    Balachandran, Sajitha
    Shetty, Suman S.
    Aziz, Zahra
    Mahal, Ajay
    BMC MEDICINE, 2020, 18 (01)
  • [37] Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program
    Thirunavukkarasu Sathish
    Brian Oldenburg
    Kavumpurathu R. Thankappan
    Pilvikki Absetz
    Jonathan E. Shaw
    Robyn J. Tapp
    Paul Z. Zimmet
    Sajitha Balachandran
    Suman S. Shetty
    Zahra Aziz
    Ajay Mahal
    BMC Medicine, 18
  • [38] Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low-and Middle-Income Countries
    Harmon, Thomas M.
    Fisher, Kevin A.
    McGlynn, Margaret G.
    Stover, John
    Warren, Mitchell J.
    Teng, Yu
    Naeveke, Arne
    PLOS ONE, 2016, 11 (01):